"tyrosine kinase" trang 10 - tải miễn phí từ tailieunhanh
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients
8    59    1
Molecular chess? Hallmarks of anti-cancer drug resistance

Molecular chess? Hallmarks of anti-cancer drug resistance
8    72    1
The non-genomic loss of function of tumor suppressors: An essential role in the pathogenesis of chronic myeloid leukemia chronic phase

The non-genomic loss of function of tumor suppressors: An essential role in the pathogenesis of chronic myeloid leukemia chronic phase
8    68    1
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
7    55    1
Pazolimus: Pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis

Pazolimus: Pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis
8    47    1
Post-crizotinib management of effective ceritinib therapy in a patient with ALKpositive non-small cell lung cancer

Post-crizotinib management of effective ceritinib therapy in a patient with ALKpositive non-small cell lung cancer
5    61    1
Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer

Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer
8    39    1
Cross-talk between the Tissue Factor/ coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer

Cross-talk between the Tissue Factor/ coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer
14    52    1
TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines

TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines
18    85    1
Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
9    35    1
Randomized phase II study of paclitaxel/ carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapynaïve non-small cell lung cancer in a clinically selected population excluding patients with nonsmoking adenocarcinoma or mutated EGFR

Randomized phase II study of paclitaxel/ carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapynaïve non-small cell lung cancer in a clinically selected population excluding patients with nonsmoking adenocarcinoma or mutated EGFR
7    39    1
Đột biến EGFR-T790M liên quan đến kháng thuốc ức chế tyrosine kinase ở bệnh nhân ung thư phổi không tế bào nhỏ

Đột biến EGFR-T790M liên quan đến kháng thuốc ức chế tyrosine kinase ở bệnh nhân ung thư phổi không tế bào nhỏ
9    56    1
Mối tương quan giữa đột biến EGFR và methyl hóa quá mức gen MGMT, MLH1, BRCA1 ở bệnh nhân ung thư phổi không tế bào nhỏ tại Bệnh viện K

Mối tương quan giữa đột biến EGFR và methyl hóa quá mức gen MGMT, MLH1, BRCA1 ở bệnh nhân ung thư phổi không tế bào nhỏ tại Bệnh viện K
5    86    1
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine

Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
13    30    1
Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
10    36    1
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations
8    58    1
Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation

Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation
14    31    1
The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
7    42    1
Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy

Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy
14    36    1
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: A retrospective case series

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: A retrospective case series
7    28    1